Process Guide
When a Surrogacy Cycle Fails: Contract, Embryos, Next Step
A failed cycle is three events with three owners: the attempt budget in the contract, the embryos left in storage, and the decisions that stay with the carrier.
- Updated
- Oct 28, 2026
- First published
- Oct 28, 2026
- Reading time
- 7 min
- By
- SurrogacyBase Medical Editorial Team
Reviewed by the SurrogacyBase Medical Advisory Board.
A cycle that does not produce a baby is not one event. It is a contractual event, a medical event that belongs to somebody else’s body, and a storage event involving embryos that are still there when everything else has stopped. Each of those three has a different document and a different decision-maker, which is why a failure that was handled well medically can still end an arrangement badly.
United States professional guidance for programs using surrogates treats all three, and reading it with a failure in mind is more useful than reading it with a success in mind.
The failure your contract already counts
The ASRM committee opinion for practices using gestational carriers requires that, before any treatment starts, the lawyer for the parties hands the treating physician a clearance letter. That letter is not a formality. Among other things it states the maximum number of embryos to transfer, the maximum number of transfer attempts agreed to, and any time limits applying to those procedures or to the arrangement itself.
So your contract contains an attempt budget and a clock, whether or not anyone said so out loud. Two things follow.
The first is that running out is not a medical judgement. If the agreement allows three transfer attempts and the fourth is refused, that is a contractual fact. Nobody has to explain it, and no clinician is being asked to decide it.
The second is that what consumes an attempt is worth knowing precisely. A cancelled cycle before retrieval, a cancelled transfer, a pregnancy loss at six weeks, a loss later in the second trimester, and a live birth that goes differently than planned are five different events, and they may be charged against five different clauses. Ask which of them draw on the attempt budget and which are treated as a fresh start. This is the same distinction the escrow page makes about money, and it is the clause most often left unspoken because nobody wants to say it in advance.
What the guidance expects you to have discussed already
The same document lists what counselling has to cover, and it is written in advance of failure rather than after it. Intended parents’ psychoeducational consultation is expected to include the risks of cancelled cycles and unsuccessful cycles, and the disposition of extra embryos. Carrier counselling is expected to cover her attitude toward pregnancy loss, reduction of a multiple pregnancy and termination, alongside her understanding of the protocol. The joint session with both sides is expected to settle the number of embryos to transfer and the number of cycles planned in the contract.
There is a reason for that insistence, and it is a hard one. The guidance lists, among grounds for refusing to proceed with a set of intended parents, a failure to follow the limits on how many embryos are transferred, or an inability to accept the carrier’s decision on that number, on selective reduction, or on ending a pregnancy. And the ethics opinion explains the underlying structure: the carrier is the sole source of consent for her own treatment from hormonal preparation and embryo transfer through delivery and aftercare.
The decision that cannot be signed away
This is the part of a failure that most surprises people who planned carefully. The ethics opinion is direct that where a disagreement arises during a pregnancy, the terms of the mutually agreed contract should prevail. It is equally direct in the next sentence that she has ultimate authority over any procedure performed on her body, and cannot be compelled to undergo one or to refuse one, whatever the contract says and whatever the consequences of a breach.
Those two sentences are not a contradiction if you read them as a division of labour. The contract governs money, information, participation and what happens when someone does not do what they promised. It does not govern her uterus. So the clause worth having is not a promise that she will accept a selective reduction, but a statement of what the parties agreed follows if she declines one, or if she accepts something you oppose. The guidance states that this is exactly what the contract should address, and that it should also say who decides if she loses capacity during the pregnancy.
It is also why arrangements are expected to stop before a transfer rather than after a dispute. The guidance says parties should discontinue the arrangement before embryo transfer where a lack of congruence or respect becomes evident during the process. A failure that happens at that stage costs medication, time and fees. The same failure discovered at twenty weeks costs considerably more, and the medical route to any decision is no longer yours to take.
The embryos are still there
A failed cycle leaves cryopreserved embryos behind more often than it leaves anything else. Guidance treats the plan for them as something to settle in advance rather than to improvise: donor and recipient counselling is expected to explore preferences about the disposition of any remaining gametes or embryos, and the intended parents’ own consultation is expected to cover disposition of extra embryos.
Three practical consequences follow.
- Storage is a running cost with its own consent form, and it continues while you are grieving, while you are deciding, and while you are renegotiating with an agency. Ask what the storage agreement says happens when the surrogacy arrangement ends.
- Changing what the embryos are for is not a small administrative step. Guidance notes that an embryo created with the intention of being used by sexually intimate partners, and later decided on for a carrier, moves into a different set of rules and documents. The same applies in reverse if an arrangement collapses and you plan to use them elsewhere.
- Where a donor’s gametes were used, their own consent may already cover what happens to what is left. Ask for that document rather than a summary of it.
What you should be handed afterwards
Before treatment starts, the guidance expects a medical release in place that authorises the practitioner to share otherwise privileged medical information with all participants. That is the instrument that makes the record of your own cycle available to you, so use it.
After a failure, ask for the primary documents rather than an account: what was transferred and how it was graded, how the uterine lining was prepared and measured, what was recorded as the reason a cycle or transfer was cancelled, and how many embryos remain in storage under which consent. A summary written for you and the record you are entitled to are not the same document, and the difference usually shows up only when a second opinion is sought.
Four questions to put before you sign
- How many transfer attempts does the contract allow, and which events consume one: cancelled retrieval, cancelled transfer, early loss, later loss, or only a birth?
- What time limit does the arrangement carry, and what happens to the agreement when it expires without a child?
- If she declines a procedure the contract anticipates, what did the parties agree follows? Ask for that clause, not for reassurance.
- Who decides about the remaining embryos, on what paperwork, and who pays to keep them stored if this arrangement ends?
Put these into the question checklist alongside the financial ones, and read the answers against the document set that should exist before a first transfer. The figures a failed cycle leaves behind, in storage fees and repeat medication, are worth entering in the cost figures tool as their own lines rather than absorbed into a package.
What the guidance does not settle
Nothing above tells you how likely a failure is. Published carrier data counts transfers, and why that number reads differently from a journey is a separate problem from the paperwork it leaves. And the guidance quoted here is written for the United States; enforceability, parentage and what a contract can require vary widely by destination, which is what the process guide and your own lawyers are for.
What is set out above is what US professional guidance states, with the dates it was written. It is not legal or medical advice, and the clauses that bind you are in your own agreement.
Sources
Every entry names the sentence above it that it supports. Open the link to read the source yourself.
- [1]Recommendations for practices using gestational carriers: a committee opinion (2022)
Fertility and Sterility 2022;118:65-74, Practice Committee of the American Society for Reproductive Medicine, published Jul 1, 2022 · checked Oct 28, 2026
Supports: That the legal clearance letter given to the treating physician states the maximum number of embryos to transfer, the maximum number of transfer attempts agreed to, and any time limits for those procedures or the arrangement; that before any treatment begins a fully executed agreement, the clearance letter, all consent documents and a medical release authorising the practitioner to share otherwise privileged medical information with all participants should be in place; that counselling of intended parents covers the risks of cancelled cycles and unsuccessful cycles and the disposition of extra embryos; that counselling of the carrier covers her attitude toward pregnancy loss, multifetal reduction and termination; that a joint session discusses the number of embryos and the number of cycles planned in the contract; that inability to follow guidance on the number of embryos transferred, or to agree with the carrier's decision on transfer number, selective reduction or termination, is a stated ground for rejecting intended parents; and that single embryo transfer is strongly recommended in carrier cycles because of the health risks multiple gestation carries for her.
- [2]Consideration of the gestational carrier: an Ethics Committee opinion (2023)
American Society for Reproductive Medicine Ethics Committee, published Apr 1, 2023 · checked Oct 28, 2026
Supports: That the carrier is the sole source of consent for her treatment from hormonal preparation and embryo transfer through delivery and aftercare; that in a disagreement during pregnancy the contract should prevail, yet she has ultimate authority over procedures on her own body and cannot be compelled to submit to or decline a procedure regardless of the contract or the consequences of a breach; that the contract should address the consequences of her refusing a previously agreed procedure or receiving one against the intended parents' wishes, and should address decision-making if she loses capacity; and that parties should discontinue the arrangement before embryo transfer where incongruence or disrespect becomes evident.
- [3]Gamete and embryo donation guidance (2024)
Fertility and Sterility 2024;122:799-813, American Society for Reproductive Medicine, published Nov 1, 2024 · checked Oct 28, 2026
Supports: That donor and recipient counselling should explore preferences about the disposition of any remaining gametes or embryos, and that a plan for the disposition of remaining embryos is an expected element of the arrangement.
Keep reading
Each of these pages covers another part of the same decision.
- Surrogacy Process Step by Step: Who Does What, and WhenGuide
- How to Check a Surrogacy Agency: 5 Documents to Ask ForGuide
- 5 Documents to Sign Before the First Embryo TransferGuide
- Escrow in Surrogacy: Who Holds the Money, When It MovesGuide
- 40,177 Transfers: What Surrogacy Success Rates CountGuide
- Reading a Surrogate's Profile: What Is Checked, What Is SalesGuide
- After a Failed Transfer, Should You Change Clinics?Guide
- Insurance in a Surrogacy Quote: The Three Policies Behind ItGuide
Your own situation
Have a consultant work through it with you
Tell us about your situation. A consultant on the editorial team replies within 1 to 2 working days, and nothing you send goes to a clinic or agency.